Trials / Completed
CompletedNCT01115179
Propofol and Perioperative Inflammation
Propofol and/or Its Solvent Modify the Course of Inflammatory Response After Surgical Stress: A Randomized, Controlled, Double-blind Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- Male
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The inflammatory properties of propofol are still under debate. Apolipoprotein A-I (Apo A-I) is involved in the inflammatory process. This study was designed to determine whether and how propofol or its solvent modulate Apo A-I and the inflammatory response after surgical stress. The investigators study hypothesis was that propofol might modify the Apo A-I blood levels, and thus, modulate the postoperative inflammatory course.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | propofol | Induction with propofol (1.5 to 2mg/kg) and maintenance of anesthesia with propofol 1% (target controlled infusion with concentration levels of 3-5 ug/ml) |
| DRUG | Intralipid 10% | Induction of anesthesia with thiopental (3-5mg/kg) and maintenance of anesthesia with isoflurane (end-expired concentration = 0.5%-2.0%) as well as the solvent of propofol 1% (Intralipid 10%; corresponding to a target-controlled infusion of propofol with concentration levels of 3-5ug/ml) |
| DRUG | Saline | Induction of anesthesia with thiopental (3-5mg/kg) and maintenance of anesthesia with isoflurane (end-expired concentration = 0.5%-2.0%) |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2010-05-04
- Last updated
- 2010-05-19
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01115179. Inclusion in this directory is not an endorsement.